Research published in early 2026 from Oxford confirms that weight regain after stopping GLP-1 medications happens faster than after behavioral weight loss programs alone roughly 0.7 pounds per month faster
In Northern Ireland, a new Regional Obesity Management Service will open in 2026 and offer patients access to weight loss medication in line with NICE guidance
Supports Stress Adaptation and Resilience Experimental data suggest DSIP may play a role in stress modulation and adaptive responses
Key points Incretins have an important role in glucose homeostasis, regulation of appetite, energy expenditure and immunity
Related Reading Glp Injections Ozempic Medication Medication Glp 1 Weight Management Peptide Pathway Guide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims